Aralkyl substituted piperazine compounds

作者: Tim Marquart , Elfatih Elzein , Prabha N. Ibrahim , Jeff Zablocki , Venkata P. Palle

DOI:

关键词: Stable anginaDonor tissueMyocardial infarctionAnesthesiaExercise-induced anginaAnginaShock (circulatory)Congestive heart diseaseIntermittent claudicationMedicine

摘要: Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein are useful in therapy to protect skeletal muscles against damage resulting from trauma or subsequent muscle systemic diseases such as intermittent claudication, treat shock conditions, preserve donor tissue organs used transplants, treatment cardiovascular including atrial ventricular arrhythmias, Prinzmetal's (variant) angina, stable exercise induced congestive heart disease, myocardial infarction.

参考文章(12)
Katalin Nogradi, Eva Againe Csongor, Ferenc Sebok, Balint Juhasz, Laszlo Czibula, Janos Galambos, Process for the preparation of piperazine derivatives ,(2009)
Paul J. Jarosz, Glenn J. Samuels, Jung-Chung Lee, Stephen Berry, Charles Lee, High dose ranolazine formulations ,(1994)
Giuseppe Bottoni, Giancarlo Santus, Ettore Bilato, Liquid-suspension controlled-release pharmaceutical composition ,(1993)
Arthur M. Strosberg, Jean-Claude G. Pascal, Robin D. Clark, Arthur F. Kluge, Roger Whiting, Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry ,(1983)
Georges Van Daele, Novel N-aryl-piperazinealkanamides ,(1982)